It is a great pleasure to announce the introduction of Novalac Aminova into Kuwait market. 

The launch webinar was led by 2 top-notch pediatrician speakers in the allergy field:

Dr. David Cremonesini from UAE & Dr. Mohamed El-Biltagi from Bahrain.

Dr. David addressed the latest updates in CMPA diagnosis and management while focusing on AAF use and positioning as per the latest guidelines. Dr. Mohamed mostly shared his clinical expertise with Aminova in Bahrain through real clinical cases that highlighted Aminova as an innovative combination like no other through its unique composition featuring PAX® complex and LC-PUFAs. A special focus on the head-to-head study vs. standard AAF was also elaborated to prove Aminova’s superiority in efficacy and safety.

This big launch leverages once again our mission of “Feeding solution for every digestive disorder” to the ultimate benefit of patients while ensuring excellence in execution.